You are here

JNJ

Tremfya, Carvykti sales grow as J&J prepares for Stelara patent loss

BioPharma Dive

Wed, 10/16/24 - 05:19 pm

J&J makes surgical robotic moves with Ottava FDA IDE application

Clinical Trials Arena

Wed, 10/16/24 - 12:31 pm

robotic surgery

J&J reports Q3 sales surge of 5.2% despite EPS decline due to M&A activity

Medical Marketing and Media

Tue, 10/15/24 - 11:30 am

On road to crowded Crohn's disease market, Lilly's Omvoh bests J&J's Stelara in head-to-head study

Fierce Pharma

Tue, 10/15/24 - 10:15 am

Crohn's Disease

clinical trials

J&J, with adult approval in sight, posts adolescent myasthenia gravis data on $6.5B FcRn blocker

Fierce Biotech

Tue, 10/15/24 - 10:10 am

myasthenia gravis

J&J discontinues late-stage study for bladder cancer drug

Reuters

Mon, 10/7/24 - 10:01 pm

clinical trials

J&J's Erleada prevails over Astellas, Pfizer’s Xtandi in real-world prostate cancer study

Fierce Pharma

Wed, 10/2/24 - 09:50 pm

prostate cancer

High-flying Eli Lilly pushes more chips forward with $4.5B 'Medicine Foundry' project

Fierce Pharma

Wed, 10/2/24 - 11:27 am

medicine foundry

drug manufacturing

Big Pharma's layoff wave in New Jersey rolls on with hundreds of J&J cuts, 57 at Bayer

Fierce Pharma

Tue, 10/1/24 - 10:19 pm

As urged by the AHA and others, J&J tells HRSA it is abandoning proposed 340B rebate plan

American Hospital Association

Mon, 09/30/24 - 09:00 pm

After Sanofi's first-line myeloma nod, J&J strikes back with new tranche of Darzalex data

Fierce Pharma

Mon, 09/30/24 - 09:30 am

Darzalex Faspro

Multiple Myeloma

J&J to shutter cardiovascular, metabolic drug unit

Seeking Alpha

Thu, 09/26/24 - 03:15 pm

cardiovascular disease

metabolic diseases

Johnson & Johnson Files for Bankruptcy Over Talc Lawsuits for the Third Time

Yahoo/Zacks.com

Mon, 09/23/24 - 10:25 pm

J&J hopes 3rd time's the charm for Texas two-step strategy as it lifts talc settlement offer to $8B

Fierce Pharma

Mon, 09/23/24 - 09:51 am

At J&J, oncology R&D meets commercial strategy in a quest for new standards of care

Pharma Voice

Thu, 09/19/24 - 09:22 am

Agency warns J&J over 340B rebate plan

Beckers Hospital Review

Wed, 09/18/24 - 12:26 pm

ESMO: J&J cues up phase 3 for Rybrevant in colorectal cancer

Pharmaphorum

Mon, 09/16/24 - 09:45 am

colorectal cancer

J&J leads $50M financing for imaging company Spectrawave

Medtech Dive

Thu, 09/12/24 - 10:20 am

Medical Imaging

venture capital

FDA expands J&J's psoriasis drug for inflammatory bowel disease

Reuters

Wed, 09/11/24 - 10:59 pm

ulcerative colitis

J&J Unveils New Branding for Medical Device Units

Medical Devices and Diagnostics Industry

Wed, 09/11/24 - 10:56 pm

Johnson & Johnson MedTech

Biosense Webster

Pages